» Authors » Falko Fend

Falko Fend

Explore the profile of Falko Fend including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 372
Citations 6737
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Matias-Guiu X, Temprana-Salvador J, Garcia Lopez P, Kammerer-Jacquet S, Rioux-Leclercq N, Clark D, et al.
Virchows Arch . 2025 Mar; PMID: 40056197
Digital Pathology (DP) revolutionizes the diagnostic workflow. Digitized scanned slides enhance operational efficiency by facilitating remote access, slide storage, reporting and automated AI image analysis, and enabling collaboration and research....
2.
Costanza M, Giordano C, von Brunneck A, Zhao J, Makky A, Vinh K, et al.
Br J Dermatol . 2025 Mar; PMID: 40036608
Background: Prognosis and quality of life of advanced cutaneous T cell lymphoma (CTCL) patients, in particular those with Sézary syndrome (SS) and advanced-stage mycosis fungoides (MF), are poor. Monoclonal antibodies...
3.
Mattern S, Hollfoth V, Bag E, Ali A, Riemenschneider P, Jarboui M, et al.
EMBO Mol Med . 2025 Feb; 17(3):441-468. PMID: 39901020
Esophagitis is a frequent, but at the molecular level poorly characterized condition with diverse underlying etiologies and treatments. Correct diagnosis can be challenging due to partially overlapping histological features. By...
4.
Veil C, Krauss F, Amend B, Fend F, Sawodny O
Sci Rep . 2025 Jan; 15(1):825. PMID: 39755796
Including sensor information in medical interventions aims to support surgeons to decide on subsequent action steps by characterizing tissue intraoperatively. With bladder cancer, an important issue is tumor recurrence because...
5.
Bajrami Saipi M, Ruiba A, Schittenhelm M, Blumenstock G, Gyorffy B, Fazio S, et al.
Cell Death Dis . 2024 Nov; 15(11):869. PMID: 39616159
Apoptosis-stimulating proteins of p53 (ASPPs) are a family of proteins that modulate key tumor suppressor pathways via direct interaction with p53. Deregulation of these proteins promotes cancer development and impairs...
6.
Spada F, Rosenwald A, Klapper W, Feller A, Fend F, Ott G, et al.
Am J Clin Pathol . 2024 Oct; 163(2):277-289. PMID: 39373181
Objectives: Primary nodal marginal B-cell lymphoma (NMZL) is rare and histologically very variable. Its large-cell presentation is difficult to distinguish from nodal diffuse large B-cell lymphoma (nDLBCL) due to the...
7.
Sherif M, Schafer H, Scharf S, van Oostendorp V, Sadeghi Shoreh Deli A, Loth A, et al.
Br J Haematol . 2024 Oct; 205(6):2327-2337. PMID: 39355919
Diffuse large B-cell lymphoma (DLBCL) represents the most prevalent aggressive B-cell lymphoma. The group is heterogeneous and the outcome is variable. A variety of approaches have been employed with the...
8.
Ilie M, Lake V, de Alava E, Bonin S, Chlebowski S, Delort A, et al.
Virchows Arch . 2024 Oct; 485(5):761-775. PMID: 39354109
Despite advancements in precision medicine, many cancer patients globally, particularly those in resource-constrained environments, face significant challenges in accessing high-quality molecular testing and targeted therapies. The considerable heterogeneity in molecular...
9.
Armbruster H, Schotte T, Gotting I, Overkamp M, Granai M, Volmer L, et al.
Virchows Arch . 2024 Aug; 485(4):631-642. PMID: 39191994
Recent studies have revealed an association between TP53 mutations and endocrine resistance in hormone receptor-positive, HER2-negative breast cancer (HR + HER2 -BC). Aberrant p53 immunostaining (IHC) patterns may provide a...
10.
Siciliano M, Bertolazzi G, Morello G, Tornambe S, Del Corvo M, Granai M, et al.
Blood Adv . 2024 Jun; 8(16):4330-4343. PMID: 38861355
Burkitt lymphoma (BL) is characterized by a tumor microenvironment (TME) in which macrophages represent the main component, determining a distinct histological appearance known as "starry sky" pattern. However, in some...